1-4 of 4
Donald Brophy
Close
Sort by
Journal Articles

Thrombelastography (TEG) and Thrombin Generation Assay (TGA) in Severe Hemophilia Following Factor Replacement Therapy

Tania T. Sarker, MD MPH, Donald Brophy, Meera B. Chitlur, MD
Journal: Blood
Blood (2015) 126 (23): 4666.
https://doi.org/10.1182/blood.V126.23.4666.4666
Published: 2015
Journal Articles

Formation of FVIIa-Antithrombin Complexes After Administration of rFVIIa to Hemophilia Patients.

Mirella Ezban, PhD, Erika Martin, MT, (ASCP), John Christian Barrett, MD, Janice Kuhn, RN, Mindy Nolte, Hermann Pelzer, Henrik Agerso, Lars Christian Petersen, Ulla Hedner, MD, PhD, Marcus E. Carr, Jr., MD, PhD, Donald Brophy, Pharm.D.
Journal: Blood
Blood (2009) 114 (22): 1295.
https://doi.org/10.1182/blood.V114.22.1295.1295
Published: 2009
Journal Articles

Evaluation of Clotting Parameters in a Patient with Hemophilia A and Inhibitors Who Has a Poor Clinical Response to Standard Dose rFVIIa.

Marcus E. Carr, Jr., MD, PhD, Erika J Martin, MT(ASCP), John Christian Barrett, MD, Mindy Nolte, RN, Janice Kuhn, RN, Mirella Ezban, PhD, Ulla Hedner, MD, PhD, Donald Brophy
Journal: Blood
Blood (2009) 114 (22): 4440.
https://doi.org/10.1182/blood.V114.22.4440.4440
Published: 2009
Journal Articles

Differences in Global Hemostasis Following rFVIIa Dosing: A Focus On Responders Versus Poor Responders.

Donald Brophy, Erika Martin, MT, (ASCP), John Christian Barrett, MD, Mindy Nolte, RN, Janice Kuhn, RN, Marcus E. Carr, Jr., MD, PhD, Mirella Ezban, PhD, Ulla Hedner, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3485.
https://doi.org/10.1182/blood.V114.22.3485.3485
Published: 2009